Two Sigma Investments’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
|
|||||
|
2025
Q1 | $191K | Sell |
|
|||||
|
2024
Q4 | $490K | Sell |
|
|||||
|
2024
Q3 | $1.61M | Sell |
|
|||||
|
2024
Q2 | $3.35M | Buy |
|
|||||
|
2024
Q1 | $1.95M | Sell |
|
|||||
|
2023
Q4 | $5.8M | Sell |
|
|||||
|
2023
Q3 | $3.5M | Sell |
|
|||||
|
2023
Q2 | $9.13M | Buy |
|
|||||
|
2023
Q1 | $10.3M | Buy |
|
|||||
|
2022
Q4 | $15.2M | Buy |
|
|||||
|
2022
Q3 | $4.24M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $860K | Sell |
|
|||||
|
2021
Q3 | $17.8M | Buy |
|
|||||
|
2021
Q2 | $25.4M | Sell |
|
|||||
|
2021
Q1 | $54.4M | Buy |
|
|||||
|
2020
Q4 | $29.3M | Sell |
|
|||||
|
2020
Q3 | $14.7M | Buy |
|
|||||
|
2020
Q2 | $7.44M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $518K | Sell |
|
|||||
|
2019
Q3 | $1.07M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.12M | Sell |
|
|||||
|
2018
Q4 | $4.21M | Sell |
|
|||||
|
2018
Q3 | $7.53M | Buy |
|
|||||
|
2018
Q2 | $1.96M | Buy |
|
|||||
|
2018
Q1 | $885K | Sell |
|
|||||
|
2017
Q4 | $1.04M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $110K | Buy |
|
|||||
|
2015
Q4 | $67K | Buy |
|
|||||
|
2015
Q3 | $66K | Buy |
|